Minerva Neurosciences (NERV) Return on Capital Employed Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | 1,398.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,398.00 |
| Dec 31, 2025 | 2,015.00 |
| Sep 30, 2025 | 1,396.00 |
| Jun 30, 2025 | 1,252.00 |
| Mar 31, 2025 | 718.00 |
| Dec 31, 2024 | -515.00 |
| Sep 30, 2024 | -2,933.00 |
| Jun 30, 2024 | -2,871.00 |
| Mar 31, 2024 | -5,619.00 |
| Dec 31, 2023 | -4,396.00 |
| Sep 30, 2023 | 449.00 |
| Jun 30, 2023 | 1,390.00 |
| Mar 31, 2023 | 6,435.00 |
| Dec 31, 2022 | 4,166.00 |
| Sep 30, 2022 | -1,498.00 |
| Jun 30, 2022 | -2,106.00 |
| Mar 31, 2022 | -2,157.00 |
| Dec 31, 2021 | -1,704.00 |
| Sep 30, 2021 | -44.00 |
| Jun 30, 2021 | -194.00 |
| Mar 31, 2021 | 3,350.00 |
| Dec 31, 2020 | 2,582.00 |
| Sep 30, 2020 | -1,157.00 |
| Jun 30, 2020 | -1,667.00 |
| Mar 31, 2020 | -8,161.00 |
| Dec 31, 2019 | -6,302.00 |
| Sep 30, 2019 | -3,232.00 |
| Jun 30, 2019 | -2,375.00 |
| Mar 31, 2019 | -902.00 |
| Dec 31, 2018 | -425.00 |
| Sep 30, 2018 | -275.00 |
| Jun 30, 2018 | 2,100.00 |
| Mar 31, 2018 | 4,663.00 |
| Dec 31, 2017 | 5,878.00 |
| Sep 30, 2017 | 5,556.00 |